Hagler Mark Arnold, President and Chief Commercial Officer purchased 230,000 shares of NovaBridge Biosciences ($NBP) @ $2.51 ($577,300.00 total) on Apr 24, 2026

Hagler Mark Arnold – President and Chief Commercial Officer

Apr 24, 2026

52W Low$0.81

Current$2.3926.5% above low, 73.5% below high

Purchase$2.5128.5% above low, 71.5% below high

52W High$6.79

230,000

Price

$2.51

Total Value

$577,300.00

P&L

-4.8% ($27,600.00)

Nearby Earnings

No earnings within 2 weeks of this transaction.

Insider	Hagler Mark Arnold
Title	President and Chief Commercial Officer
Transaction Date	Apr 24, 2026
Transaction Code	P Purchase
Acquired/Disposed	Acquired
Security	Ordinary Shares
Direct/Indirect	Direct
Filing Date	Apr 28, 2026
Shares Purchased	230,000
Price per Share	$2.51
Total Value	$577,300.00
Shares Owned After	230,000
Derivative	No
Accession Number	0001193125-26-186924
Document	View SEC Filing